1. Home
  2. HALO vs QXO Comparison

HALO vs QXO Comparison

Compare HALO & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • QXO
  • Stock Information
  • Founded
  • HALO 1998
  • QXO 1988
  • Country
  • HALO United States
  • QXO United States
  • Employees
  • HALO N/A
  • QXO N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • QXO EDP Services
  • Sector
  • HALO Health Care
  • QXO Technology
  • Exchange
  • HALO Nasdaq
  • QXO Nasdaq
  • Market Cap
  • HALO 6.4B
  • QXO 6.5B
  • IPO Year
  • HALO N/A
  • QXO N/A
  • Fundamental
  • Price
  • HALO $50.51
  • QXO $16.10
  • Analyst Decision
  • HALO Buy
  • QXO
  • Analyst Count
  • HALO 9
  • QXO 0
  • Target Price
  • HALO $61.11
  • QXO N/A
  • AVG Volume (30 Days)
  • HALO 1.3M
  • QXO 2.0M
  • Earning Date
  • HALO 02-18-2025
  • QXO 11-13-2024
  • Dividend Yield
  • HALO N/A
  • QXO N/A
  • EPS Growth
  • HALO 61.71
  • QXO N/A
  • EPS
  • HALO 3.02
  • QXO N/A
  • Revenue
  • HALO $947,355,000.00
  • QXO $56,838,941.00
  • Revenue This Year
  • HALO $23.36
  • QXO $3.75
  • Revenue Next Year
  • HALO $15.35
  • QXO $13,174.40
  • P/E Ratio
  • HALO $16.69
  • QXO N/A
  • Revenue Growth
  • HALO 21.35
  • QXO 8.86
  • 52 Week Low
  • HALO $33.15
  • QXO $10.61
  • 52 Week High
  • HALO $65.53
  • QXO $290.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 59.63
  • QXO 50.97
  • Support Level
  • HALO $47.52
  • QXO $15.13
  • Resistance Level
  • HALO $49.00
  • QXO $16.05
  • Average True Range (ATR)
  • HALO 1.39
  • QXO 0.69
  • MACD
  • HALO 0.38
  • QXO -0.01
  • Stochastic Oscillator
  • HALO 93.30
  • QXO 54.11

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About QXO QXO Inc. Common Stock

QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution and service sectors. It provides consulting and professional services, specialized programming, training and technical support also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence and other applications. Additionally, QXO develops and publishes its own proprietary software.

Share on Social Networks: